Strata Critical Medical (SRTA) Payables (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Payables data on file, last reported at $20.0 million in Q1 2026.

• Payables for Q1 2026 came in at $20.0 million, up 89.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (up 89.96% YoY), and the FY2025 annual result was $19.1 million, up 107.61% from the prior year.
• Payables rose to $20.0 million in Q1 2026 per SRTA's latest filing, from $19.1 million in the prior quarter.
• Over five years, Payables peaked at $27.2 million in Q3 2025 and troughed at $7.6 million in Q2 2022.
• A 5-year average of $15.1 million and a median of $14.9 million in 2023 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables soared 589.67% in 2022, then slumped 61.36% in 2024.
• A 5-year view of Payables shows it stood at $16.5 million in 2022, then soared by 44.29% to $23.9 million in 2023, then tumbled by 61.36% to $9.2 million in 2024, then surged by 107.61% to $19.1 million in 2025, then grew by 4.25% to $20.0 million in 2026.
• Business Quant data shows SRTA's Payables at $20.0 million in Q1 2026, $19.1 million in Q4 2025, and $27.2 million in Q3 2025.